DATATRAK Participates in SCDM 2013

CLEVELAND, Sept. 3, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced three of its team members will address current industry topics at the annual Society for Clinical Data Management (SCDM) conference in Chicago, September 10 - 13. In addition, DATATRAK will be exhibiting its DATATRAK ONE™ software suite in Booth 510 at the River Hall in the Sheraton Chicago Hotel & Towers.

(Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

Learn from DATATRAK Thought Leaders at the following sessions:

Date & Time:

September 11, 2013; 11:00 am – 12:30 pm

Speaker:

Aaron Gadberry, Director of Software Architecture

Topic:

"Gathering and Leveraging Quality-Centric Metadata in Clinical Trials"



Date & Time:

September 12, 2013; 3:30 – 5:30 pm

Speaker:

Bill O'Mara, Manager of Clinical Data Management

Topic:  

"When Outsourcing, Technology and Procedures around the Technology are both Important"



Date & Time:

September 13, 2013; 8:15 – 9:45 am

Speaker:

Dr. Bill Gluck, Vice President of Clinical & Consulting Services

Topic: 

"The Changing Roles and Adjustments to Current Workflows and Processes to Implement a Risk-Based Approach to Monitoring"

About DATATRAK

DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.com.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on August 12, 2013 announcing its results for the second quarter of 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.



RELATED LINKS
http://www.datatrak.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.